Hyperliquid (HYPE) price fell below $40 amid profit-taking and crypto sell-off.
Despite positive news with Eyenovia announcing plans to add HYPE to treasury strategy, the price dipped 5%.
Bears may target deeper price dips if bulls give up territory.
Hyperliquid (HYPE) dropped more than 5% on June 18, 2025, falling below the $40 mark even as Eyenovia, Inc.—a Nasdaq-listed ophthalmic technology firm—announced a $50 million investment in the token as part of its crypto treasury strategy.
The move marks a significant milestone for both firms.
Eyenovia’s announcement aligns with a broader trend of publicly traded companies increasing exposure to digital assets, adding crypto to their balance sheets amid growing institutional interest.
Despite the bullish headline, HYPE extended losses following a recent all-time high, with the decline largely attributed to profit-taking.
The price action leaves the Hyperliquid token vulnerable to further downside if selling pressure persists.
Big news as Eyenovia plans HYPE treasury strategy
On June 17, 2025, Eyenovia announced its plans for a private placement as it looks to establish a cryptocurrency treasury reserve.
Specifically, the company wants its balance sheet to include Hyperliquid’s native token, HYPE.
This strategic pivot, which includes rebranding to Hyperion DeFi, aims to position Eyenovia as a leading validator on the Hyperliquid blockchain..
Notably, Eyenovia’s $50 million investment targets the acquisition of 1 million HYPE tokens.
Once executed, the company will become one of the top global validators on Hyperliquid’s layer-1 blockchain.
The $50 million financing, secured through a private placement in public equity (PIPE) with institutional investors, involves issuing convertible preferred stock at $3.25 per share, potentially raising up to $150 million if warrants are fully exercised.
Eyenovia has appointed Hyunsu Jung as Chief Investment Officer to lead this initiative, with plans to stake HYPE tokens via Anchorage Digital’s platform.
Eyenovia’s chief executive officer, Michael Rowe, emphasized the strategy’s focus on long-term capital appreciation and shareholder value, citing Hyperliquid’s rapid growth and $8.4 million daily revenue.
This move aligns with a growing trend among publicly traded companies diversifying into cryptocurrency treasuries.
Strategy, formerly MicroStrategy, is the biggest player with its over $60 billion Bitcoin (BTC) haul.
Other companies have announced strategies for Ethereum, XRP, and Solana.
Eyenovia stands out as the first US public company to adopt HYPE, potentially setting a precedent for decentralized finance (DeFi) tokens.
“We are pleased to join the growing number of companies who have adopted similar strategies for the diversification, liquidity and long-term capital appreciation potential that cryptocurrency represents,” stated Michael Rowe, chief executive officer of Eyenovia.
“Following a thorough review of all available alternatives, the Board and I have concluded that this transaction is in the best interests of our shareholders.”
What is the outlook for the HYPE price?
HYPE’s price has struggled to maintain momentum above $40, dropping to $39.89 after failing to sustain a recent peak of $45.50.
On the daily chart, technical indicators paint a bearish picture, with the Relative Strength Index (RSI) sitting at 45.6, indicating neutral momentum with a slight bearish tilt, while the Moving Average Convergence Divergence (MACD) shows weakening bullish momentum.
Open Interest (OI) on Hyperliquid futures has also declined, signaling reduced trader confidence, according to Coinglass data.
Despite the current price dip, analysts forecast that such institutional endorsements could drive HYPE’s value higher.
Moreover, Hyperliquid remains a strong project with massive perpetuals volume and revenue.
